Axsome Therapeutics, Inc. (AXSM)
NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
As of 11:14AM EDT. Market open.
Currency in USD
Valuation measures4
| Market cap (intra-day) | 3.39B |
| Enterprise value | 3.19B |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG ratio (5-yr expected) | N/A |
| Price/sales (ttm) | 12.01 |
| Price/book (mrq) | 17.74 |
| Enterprise value/revenue | 11.78 |
| Enterprise value/EBITDA | -14.17 |
Trading information
Stock price history
| Beta (5Y monthly) | 1.10 |
| 52-week change 3 | -0.01% |
| S&P500 52-week change 3 | 21.08% |
| 52-week high 3 | 98.40 |
| 52-week low 3 | 55.02 |
| 50-day moving average 3 | 76.00 |
| 200-day moving average 3 | 74.79 |
Share statistics
| Avg vol (3-month) 3 | 725.53k |
| Avg vol (10-day) 3 | 581.57k |
| Shares outstanding 5 | 47.37M |
| Implied shares outstanding 6 | 47.37M |
| Float 8 | 34.88M |
| % held by insiders 1 | 17.12% |
| % held by institutions 1 | 83.50% |
| Shares short (15 Apr 2024) 4 | 7.75M |
| Short ratio (15 Apr 2024) 4 | 11.26 |
| Short % of float (15 Apr 2024) 4 | 19.69% |
| Short % of shares outstanding (15 Apr 2024) 4 | 16.36% |
| Shares short (prior month 15 Mar 2024) 4 | 7.3M |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 31 Dec 2023 |
| Most-recent quarter (mrq) | 31 Dec 2023 |
Profitability
| Profit margin | -88.41% |
| Operating margin (ttm) | -77.68% |
Management effectiveness
| Return on assets (ttm) | -24.86% |
| Return on equity (ttm) | -159.21% |
Income statement
| Revenue (ttm) | 270.6M |
| Revenue per share (ttm) | 5.96 |
| Quarterly revenue growth (yoy) | 193.50% |
| Gross profit (ttm) | N/A |
| EBITDA | -182.45M |
| Net income avi to common (ttm) | -239.24M |
| Diluted EPS (ttm) | -5.27 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | 386.19M |
| Total cash per share (mrq) | 8.15 |
| Total debt (mrq) | 186.37M |
| Total debt/equity (mrq) | 97.59% |
| Current ratio (mrq) | 3.63 |
| Book value per share (mrq) | 4.03 |
Cash flow statement
| Operating cash flow (ttm) | -145.08M |
| Levered free cash flow (ttm) | -78.72M |
© 2024 Yahoo. All rights reserved.